22.07.2024
Local drug delivery over a longer period of time: this is one of the challenges that doctors face when treating wounds and inflammations. Empa researchers have now developed a promising solution: “liquid core fibers” that contain drugs inside them and can deliver them precisely over a longer period of time.12.04.2024
The start-up goatAM wants to commercialize 3D printing technology for pharmaceuticals. goatAM CEO Tilmann Spitz and Dr. Julian Quodbach from Utrecht University explain the advantages of the process, why the individual dosing of drugs in 3D printing makes sense and how the properties of the polymers influence the release of the drugs.15.11.2023
Sometimes the smallest part can have the biggest impact! One such component is the RondelO from the Swedish company CYTO365 AB. The infusion distributor helps hospital staff avoid errors when caring for patients. CEO Micael Törnblom explains how in a COMPAMED interview!13.07.2023
KIMM develops the world’s first 3D bioprinting technology that enhances the function of NK immune cells. The new technology is expected to improve effectiveness of cancer treatment.01.06.2023
Using a newly developed method for the efficient and cost-effective production of biocompatible microfibres, the production of autologous skin and organs can be significantly accelerated.21.03.2023
mRNA-based vaccines have been one of the key elements in the fight against the coronavirus. The technology was originally developed for cancer therapy and can be used to treat many diseases. Together with partners, Fraunhofer IPK is now researching how mRNA therapeutics and other medication can be better produced and more effectively applied.15.02.2023
Scientists from the Micro, Nano and Molecular Systems Lab at the Max Planck Institute for Medical Research and the Institute for Molecular Systems Engineering and Advanced Materials at Heidelberg University have created a new technology to assemble matter in 3D. Their concept uses multiple acoustic holograms to generate pressure fields.